We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Noninvasive Stool Test Biased by Patient's Age

By LabMedica International staff writers
Posted on 24 Apr 2012
Print article
A DNA methylation test for colorectal cancer (CRC) is influenced by the clinical variable age and not by drug choice or other variables.

Stool assays of carefully selected methylated gene-marker candidates yield high detection rates of both CRC and large adenomas as aberrantly methylated genes represent attractive and broadly informative markers for these forms of malignancy.

Scientists at the Mayo Clinic (Rochester, MN, USA) collected buffered stools within three years of a normal colonoscopy from 500 patients undergoing average-risk screening or polyp surveillance. The median age was 64 years old, with a range of 44-85 and 53% were women. The stool samples were promptly homogenized, aliquoted, and frozen at -80 °C.

Target genes were purified by hybrid capture from thawed and centrifuged aliquot supernatants, bisulfite treated, and assayed using the quantitative allele-specific real-time target and signal amplification the analytically-sensitive (QuARTS) method. The reference gene β-actin was assayed along with methylation of the N-Myc Downstream-Regulated gene 4 (NDRG4), Bone Morphogenetic Protein 3 gene (BMP3), the Vimentin gene, and the Tissue Factor Pathway Inhibitor 2 gene (TFPI2).

The only patient characteristic that significantly influenced all methylated marker levels in stool was age. Standardized relative change was greatest with TFPI2 at +91.3, least with BMP3 at +29.7, and intermediate with vimentin at +46.0 and NDRG4 at +45.1. David Ahlquist, MD, professor of medicine at the Mayo Clinic, said, "There was a progressive increase in background methylation levels that varied widely between methylation markers tested as a patient aged. For example, median background methylation levels of the TFPI2 gene increased 49% in patients from age 50 to age 80, whereas levels for the BMP3 gene increased by only 0.2% across this age range." The study was presented at the American Association for Cancer Research Annual Meeting, held March 31 - April 4, 2012, in Chicago (IL, USA).

Related Links:

Mayo Clinic


New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Unit-Dose Packaging solution
HLX
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
New
Vedolizumab ELISA
RIDASCREEN VDZ Monitoring

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.